Asked by Mindy Gracie Butler on Jun 15, 2024
Verified
When used for treatment of patients diagnosed with Alzheimer disease, which medication would be expected to antagonize N-methyl-D-aspartate (NMDA) channels rather than cholinesterase?
A) Donepezil (Aricept)
B) Rivastigmine (Exelon)
C) Memantine (Namenda)
D) Galantamine (Razadyne)
N-Methyl-D-Aspartate
A chemical compound that acts as a specific receptor for the neurotransmitter glutamate, playing a role in brain functions like learning and memory.
Cholinesterase
An enzyme necessary for the proper functioning of the nervous system, breaking down neurotransmitters like acetylcholine.
Memantine
A medication primarily used in the management of Alzheimer's disease by acting on the glutamatergic system.
- Gain insight into the physiological and pathological transformations associated with Alzheimer's disease and different dementias.
- Assess the impact of pharmaceutical treatments on individuals suffering from cognitive impairments.
Verified Answer
Learning Objectives
- Gain insight into the physiological and pathological transformations associated with Alzheimer's disease and different dementias.
- Assess the impact of pharmaceutical treatments on individuals suffering from cognitive impairments.
Related questions
An Older Adult Takes Digoxin and Hydrochlorothiazide Daily, as Well ...
Consider These Problems: Apolipoprotein E (ApoE) Malfunction, Neuritic Plaques, Neurofibrillary ...
Consider These Health Problems: Lewy Body Disease, Pick Disease, and ...
Alzheimer's Disease Usually Begins with ...
The MOST Frequent Type of Neurocognitive Disorder in the Elderly ...